- cafead Mar 16, 2023 at 09:42: AM
via Seamless Therapeutics has launched with €11.8 million (roughly $12.5 million) in seed funding to build out a gene editing platform.
As more and more gene editing techniques are being developed — starting with CRISPR/Cas9 to base and prime editing, and more recently, PASTE — Seamless is trying to evolve, literally, an approach that dates back decades.
article source
As more and more gene editing techniques are being developed — starting with CRISPR/Cas9 to base and prime editing, and more recently, PASTE — Seamless is trying to evolve, literally, an approach that dates back decades.
article source